Drug delivery company FeRx raises $15 million:
This article was originally published in Clinica
Executive Summary
Drug delivery company FeRx has completed a $15m private placement. The San Diego-based company's MTC (magnetic targeted carrier) technology is used to improve patient care, reduce toxicity and increase efficacy of known drugs for the treatment of cancer. MTCs are microparticles composed of metallic iron and activated carbon.